Notice: Get a jump on 2015 — Pay your 2015 ASA membership dues now!

>

MEETINGS / EVENTS

RSS

January 23 - 25 2015, 12:00 AM - 12:00 AM

ASA PRACTICE MANAGEMENT 2015

February 07 - 08 2015, 12:00 AM - 12:00 AM

ASA Certificate in Business Administration 2015

June 26 - 28 2015, 12:00 AM - 12:00 AM

Annual Perioperative Surgical Home Summit

>

FDA MEDWATCH ALERTS

December 18, 2014

0.9 Percent Sodium Chloride Injection USP in 100 mL MINI-BAG PLUS Container by Baxter: Recall - Particulate Matter

Summary:

FDA MedWatch Recall - Particulate Matter

November 21, 2014

FDA MedWatch - Respironics California, Esprit V1000 and V200 Ventilators: Class I Recall - Power Failure May Occur

Summary:

FDA MedWatch Respironics California Esprit V1000 and V200 Ventilators Class I Recall

November 21, 2014

FDA MedWatch - Highly Concentrated Potassium Chloride Injection, 10 mEq per 100 mL by Baxter: Recall - Mislabeled

Summary:

Highly Concentrated Potassium Chloride Injection 10 mEq per 100 mL by Baxter Recall Mislabeled

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Self-Education and Evaluation (SEE) Program

SKU: 30701-14CE

... Read more »

Single Copies, Member Price: $360

Study Showed Stimulant Medication Helped ‘Wake Up’ Animals From General Anesthesia

Chicago — (September 21, 2011) 

A study published in October’s issue of Anesthesiology found that methylphenidate, a drug used in patients to treat attention deficit hyperactivity disorder, when given to rats while under general anesthesia caused them to awaken faster from anesthesia when compared to rats that didn’t receive the stimulant.

“We are only beginning to learn about which pathways in the brain are important for emerging from general anesthesia,” said lead study investigator Ken Solt, M.D.  “Our study suggests that methylphenidate may wake up animals from general anesthesia by activating dopamine- and norepinephrine-mediated arousal pathways.”

About the Study

Investigators used adult rats to test the effect of methylphenidate on time to emergence from general anesthesia. They also performed experiments to test the effects of methylphenidate on sedation and respiratory depression by general anesthesia. Electroencephalogram (EEG) recordings showed that the brain developed an arousal pattern, confirming the animals “woke up” after being given methylphenidate. Measurements of respiratory rate, as well as oxygen and carbon dioxide levels within the blood, confirmed that methylphenidate also reversed respiratory depression in the animals.

Investigators found that administering methylphenidate lessened the time from end of anesthesia to awakening by three fold.  

This finding offers a new perspective for scientists on the process of emergence from anesthesia. Currently, physicians wait for the anesthetics to wear off. In a few cases, antidotes to reverse drugs like muscle relaxants and narcotic analgesics can be administered. There are no receptor antagonists to reverse sedation and respiratory depression from general anesthesia.    

“In this study, methylphenidate helped to overcome the effects of the general anesthetic by activating brain arousal centers,” said Dr. Solt.  “More research needs to be done to confirm the value of the use of methylphenidate in anesthesia emergence.”

THE AMERICAN SOCIETY OF ANESTHESIOLOGISTS

Founded in 1905, the American Society of Anesthesiologists (ASA) is an educational, research and scientific society with more than 52,000 members organized to raise and maintain the standards of the medical practice of anesthesiology. ASA is committed to ensuring physician anesthesiologists evaluate and supervise the medical care of patients before, during and after surgery to provide the highest quality and safest care every patient deserves.

For more information on the field of anesthesiology, visit the American Society of Anesthesiologists online at asahq.org . To learn more about the role physician anesthesiologists play in ensuring patient safety, visit asahq.org/WhenSecondsCount. Like ASA on Facebook , follow ASALifeline on Twitter and follow ASA on LinkedIn .

###

Contact:

American Society of Anesthesiologists
pr@asahq.org
847-825-5586